Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent, Persistent or Metastasized Cervical Cancer”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT05817214
What this trial is testing

Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer

Who this might be right for
Cervical Cancer
Zhongnan Hospital 35
Testing effectiveness (Phase 2)Study completedNCT01094405
What this trial is testing

Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy

Who this might be right for
Nasopharyngeal CancerEpstein-Barr Virus Infections
Chinese University of Hong Kong 25
Large-scale testing (Phase 3)UnknownNCT01405235
What this trial is testing

Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma

Who this might be right for
Recurrent, Persistent or Metastasized Cervical Cancer
Institut fuer Frauengesundheit 312
Testing effectiveness (Phase 2)Study completedNCT00100789
What this trial is testing

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 67

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation